Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 04 2018 - 8:00AM
Horizon Pharma plc (NASDAQ:HZNP) today announced that the
compensation committee of its board of directors approved the grant
on Apr. 1, 2018 of inducement restricted stock units for an
aggregate of 55,395 ordinary shares to 21 new employees.
Some of the restricted stock units vest over four years, with
1/4 of the shares vesting on each anniversary of the applicable
vesting commencement date, and some of the restricted stock units
vest over three years, with 1/3 of the shares vesting on each
anniversary of the applicable vesting commencement date. All awards
are subject to the new employee's continued service relationship
with the Company. Each restricted stock unit also is subject
to the terms and conditions of the Company's 2014 Equity Incentive
Plan and the restricted stock unit agreement pursuant to which the
restricted stock unit was granted.
The restricted stock units were granted as inducements material
to the new employees entering into employment with Horizon Pharma
in accordance with NASDAQ Listing Rule 5635(c)(4).
About Horizon Pharma plcHorizon Pharma plc is
focused on researching, developing and commercializing innovative
medicines that address unmet treatment needs for rare and rheumatic
diseases. By fostering a growing pipeline of medicines in
development and exploring all potential uses for currently marketed
medicines, we strive to make a powerful difference for patients,
their caregivers and physicians. For us, it’s personal: by
living up to our own potential, we are helping others live up to
theirs. For more information, please
visit www.horizonpharma.com.
Follow @HZNPplc on Twitter, like us
on Facebook or explore career opportunities
on LinkedIn.
Contacts:Tina VenturaSenior Vice President,
Investor RelationsInvestor-relations@horizonpharma.com
Ruth VenningExecutive Director, Investor
RelationsInvestor-relations@horizonpharma.com
U.S. Media Contact:Geoffrey CurtisSenior Vice President,
Corporate Affairs and Chief Communications
Officermedia@horizonpharma.com
Ireland Media Contact: Ray Gordon Gordon MRM
ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024